Text this: Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS)

           __   __    _____      ___    __    __  
  ____     \ \\/ //  |__  //    / _ \\  \ \\ / // 
 |    \\    \ ` //     / //    / //\ \\  \ \/ //  
 | [] ||     | ||     / //__  |  ___  ||  \  //   
 |  __//     |_||    /_____|| |_||  |_||   \//    
 |_|`-`      `-`'    `-----`  `-`   `-`     `     
 `-`